ONO 3708

Drug Profile

ONO 3708

Alternative Names: ONO-3708 (TXA2/PGH2 receptor antagonist)

Latest Information Update: 01 Jun 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Class Antiasthmatics; Antiplatelets; Small molecules
  • Mechanism of Action Prostaglandin receptor antagonists; Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Hypertension; Ischaemic heart disorders; Thrombosis

Most Recent Events

  • 01 Jun 2011 Discontinued - Phase-II for Ischaemic heart disorders in Japan (unspecified route)
  • 01 Jun 2011 Discontinued - Phase-II for Thrombosis in Japan (unspecified route)
  • 01 Jun 2011 Discontinued for Asthma in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top